PD-1 inhibitors versus chemotherapy as second-line treatment for advanced esophageal squamous cell carcinoma: a meta-analysis

BACKGROUND: Aim to establish the inhibitors of programmed cell death protein 1 (PD-1) as second-line therapy for advanced esophageal squamous cell carcinoma (ESCC). METHODS: Published clinical trials in the PubMed, Medline, Embase databases on PD-1 inhibitors for the treatment of ESCC were searched,...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Xinxin, Shanzhou, Qiyue, Li, Danyang, Pang, Xuezhou, Ma, Daiyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8579527/
https://www.ncbi.nlm.nih.gov/pubmed/34758782
http://dx.doi.org/10.1186/s12885-021-08958-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8579527/
https://www.ncbi.nlm.nih.gov/pubmed/34758782
http://dx.doi.org/10.1186/s12885-021-08958-3

Ejemplares similares